1
Breems, Dimitri A., Boogaerts, Marc A., Dekker, Adriaan W., Van Putten, Wim L. J., Sonneveld, Pieter, Huijgens, Peter C., Van der Lelie, Johannes, Vellenga, Edo, Gratwohl, Alois, Verhoef, Gregor E. G., Verdonck, Leo F., Löwenberg, Bob
Veröffentlicht in: British Journal of Haematology ; volume 128, issue 1, page 59-65 ; ISSN 0007-1048 1365-2141;
2004
Veröffentlicht in: British Journal of Haematology ; volume 128, issue 1, page 59-65 ; ISSN 0007-1048 1365-2141;
2004
2
3
Dierickx, Daan, Connerotte, Thierry, Dallemagne, Julie, Becker, Ann De, Moors, Ine, Snauwaert, Sylvia, Sonet, Anne, Theunissen, Koen, Breems, Dimitri, Prijck, Bernard De, Jaspers, Aurélie, Lambert, Catherine, Heyrman, Bert, Hautekiet, Joris, Lyna, Sofie, Maertens, Chantal, Delrieu, Vanessa
Veröffentlicht in: HemaSphere ; volume 7, issue S3, page e93798cb ; ISSN 2572-9241;
2023
Veröffentlicht in: HemaSphere ; volume 7, issue S3, page e93798cb ; ISSN 2572-9241;
2023
4
5
Ossenkoppele, Gert Jan, Stussi, Georg, Maertens, Johan, van Montfort, Kees, Biemond, Bart J., Breems, Dimitri, Ferrant, August, Graux, Carlos, de Greef, Georgine E., Halkes, C. J. M., Hoogendoorn, Mels, Hollestein, Rene M., Jongen-Lavrencic, Mojca, Levin, Mark-David, van de Loosdrecht, Arjan A., Kooij, Marinus van Marwijk, van Norden, Yvette, Pabst, Thomas, Schouten, Harry C., Vellenga, Edo, Verhoef, Gregor E. G., de Weerdt, Okke, Wijermans, Pierre, Passweg, Jakob R., Lowenberg, Bob
Veröffentlicht in: Ossenkoppele , G J , Stussi , G , Maertens , J , van Montfort , K , Biemond , B J , Breems , D , Ferrant , A , Graux , C , de Greef , G E , Halkes , C J M , Hoogendoorn , M , Hollestein , R M , Jongen-Lavrencic , M , Levin , M-D , van de Loosdrecht , A A , Kooij , M V M , van Norden , Y , Pabst , T , Schouten , H C , Vellenga , E , Verhoef , G E G , de Weerdt , O , Wijermans , P , Passweg , J R & Lowenberg , B 2012 , ' Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK) ' , Blood , vol. 120 , no. 24 , pp. 4706-4711 . https://doi.org/10.1182/blood-2012-04-420596;
2012
Veröffentlicht in: Ossenkoppele , G J , Stussi , G , Maertens , J , van Montfort , K , Biemond , B J , Breems , D , Ferrant , A , Graux , C , de Greef , G E , Halkes , C J M , Hoogendoorn , M , Hollestein , R M , Jongen-Lavrencic , M , Levin , M-D , van de Loosdrecht , A A , Kooij , M V M , van Norden , Y , Pabst , T , Schouten , H C , Vellenga , E , Verhoef , G E G , de Weerdt , O , Wijermans , P , Passweg , J R & Lowenberg , B 2012 , ' Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK) ' , Blood , vol. 120 , no. 24 , pp. 4706-4711 . https://doi.org/10.1182/blood-2012-04-420596;
2012
6
Ossenkoppele, Gert J, Stussi, Georg, Maertens, Johan, van Montfort, Kees, Biemond, Bart J, Breems, Dimitri, Ferrant, August, Graux, Carlos, de Greef, Georgine E, Halkes, C J M, Hoogendoorn, Mels, Hollestein, Rene M, Jongen-Lavrencic, Mojca, Levin, Mark D, van de Loosdrecht, Arjan A, van Marwijk Kooij, Marinus, van Norden, Yvette, Pabst, Thomas, Schouten, Harry C, Vellenga, Edo, Verhoef, Gregor E G, de Weerdt, Okke, Wijermans, Pierre, Passweg, Jakob R, Löwenberg, Bob
2012
2012